{"id":"W4386948667","doi":"10.1016/j.ygyno.2023.06.566","title":"Maveropepimut-S, an immune-educating therapy with durable clinical benefit in patients with recurrent ovarian cancer (180)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Survivin; Medicine; Ovarian cancer; Immune system; CD8; Cyclophosphamide; Oncology; Chemotherapy; Immunotherapy; T cell; Internal medicine; Cancer; Cancer research; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001526338,0.0001455701,0.0002786243,0.000141898,0.0001251079,0.0002160744,0.000145636,0.0002370589,0.001633509],"category_scores_gemma":[0.0001840081,0.00004315716,0.0002498406,0.0001429143,0.00008543037,0.0001176963,0.000109609,0.0004921181,0.0002302765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001432461,"about_ca_system_score_gemma":0.0002159377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004916895,"about_ca_topic_score_gemma":0.001198114,"domain_scores_codex":[0.9999703,0.00000689129,0.000002050438,0.000003525966,0.000004137881,0.00001301542],"domain_scores_gemma":[0.9999559,0.00001030877,0.000008802971,0.000005212753,0.000004338935,0.00001545835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01043823,0.002514,0.01026348,0.0005354773,0.0003881051,0.0008101191,0.0001040981,0.001037427,0.1236532,0.001142696,0.01066091,0.8384523],"study_design_scores_gemma":[0.0322226,0.2431415,0.2674413,0.000407474,0.001671139,0.01245192,0.0004232671,0.005562999,0.2016355,0.00311279,0.2318393,0.00009008642],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691519,0.01537404,0.001072736,0.001705618,0.0002945443,0.0002223394,0.0006106854,0.0002536623,0.01131445],"genre_scores_gemma":[0.9889216,0.004770208,0.001043856,0.0009139084,0.0001039907,0.0000908081,0.0008711564,0.00001562136,0.003268825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001633509,"threshold_uncertainty_score":0.005464613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03423793552204878,"score_gpt":0.3317496263156813,"score_spread":0.2975116907936325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}